[1]陈懿榕,阙任烨,刘进锴,等.柴胡皂苷d对大鼠肝星状细胞TGFβ-Smad信号通路mRNA表达的影响[J].西部中医药,2022,35(08):15-19.[doi:10.12174/j.issn.2096-9600.2022.08.04]
 CHEN Yirong,QUE Renye,LIU Jinkai,et al.Influence of Saikosaponins-d on the Expressions of TGFβ-Smad Signal Path mRNA in Rat Hepatic Stellate Cells[J].Western Journal of Traditional Chinese Medicine,2022,35(08):15-19.[doi:10.12174/j.issn.2096-9600.2022.08.04]
点击复制

柴胡皂苷d对大鼠肝星状细胞TGFβ-Smad信号通路mRNA表达的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年08期
页码:
15-19
栏目:
出版日期:
2022-08-15

文章信息/Info

Title:
Influence of Saikosaponins-d on the Expressions of TGFβ-Smad Signal Path mRNA in Rat Hepatic Stellate Cells
作者:
陈懿榕1, 阙任烨2, 刘进锴3, 林柳兵1, 李勇1
1.上海中医药大学附属市中医医院,上海 200071
2.上海中医药大学附属上海市中西医结合医院
3.第二军医大学附属东方肝胆外科医院
Author(s):
CHEN Yirong1, QUE Renye2, LIU Jinkai3, LIN Liubing1, LI Yong1
1.Shanghai City Hospital of Traditional Chinese Medicine, Shanghai 200041, China
2.Shanghai TCM-integrated Hospital, Shanghai University of TCM
3.Eastern Hepatobiliary Surgery Hospital affiliated to the Second Military Medical University
关键词:
肝纤维化柴胡皂苷d雌二醇肝星状细胞TGF-Smad信号通路动物实验大鼠
Keywords:
liver fibrosisSSdestradiolHSC-T6TGF-Smad signal pathwayanimal experimentrat
分类号:
R575.2
DOI:
10.12174/j.issn.2096-9600.2022.08.04
摘要:
目的观察柴胡皂苷d(saikosaponins-d,SSd)对肝星状细胞TGFβ1、Smad3/7mRNA表达的影响。 方法采用大鼠肝星状细胞(hepatic stellate cell-T6,HSC-T6)为模型,采用药物进行干预后加入H2O2诱导氧化应激,采用RT-PCR实验方法检测TGFβ1、Smad3/7 mRNA表达。 结果与空白组比较,模型组TGFβ1、Smad3表达增强,Smad7表达减弱(P<0.05)。与模型组比较,SSd组干预后HSC-T6细胞中TGFβ1、Smad3 mRNA水平降低,Smad7 mRNA水平增高(P<0.05)。这种作用可被雌激素受体(estrogen receptor,ER)完全拮抗剂和ERβ拮抗剂阻滞。 结论SSd能下凋TGFβ1、Smad3 mRNA表达,上调 Smad7 mRNA的表达,对HSC-T6的TGFβ-Smad信号通路有明显的影响,可能是SSd对肝纤维化产生治疗作用的机制之一。
Abstract:
ObjectiveTo observe the effects of SSd on the expressions of TGFβ1, Smad3/7mRNA in hepatic stellate cells. MethodsRat HSC-T6 were adopted as the model, after drug intervention, H2O2 was added to induce oxidative stress, RT-PCR was used to detect the expressions of TGFβ1, Smad3/7mRNA. ResultsCompared with the blank group, the expression of TGFβ1 and Smad3 in the model group was enhanced, while the expression of Smad7 was weakened (P<0.05). Compared with the model group, the levels of TGFβ1 and Smad3 mRNA were decreased while the level of Smad7mRNA was elevated in HSC-T6 cells in SSd group after the intervention (P<0.05). The effects could be blocked by ER complete antagonist and ERβ antagonist. ConclusionSSd could down regulate the expressions of TGFβ1, Smad3 mRNA, up regulate the expressions of Smad7 mRNA, and it could affect TGFβ-Smad signal pathway in HSC-T6 signal pathway, which might be one of the mechanisms of SSd producing therapeutic effects on liver fibrosis.

相似文献/References:

[1]于立友,汪龙德△,张晶,等.化纤保肝方治疗气滞血瘀型肝纤维化的临床研究*[J].西部中医药,2013,26(10):84.
 YU Liyou,WANG Longde,ZHANG Jing,et al.Clinical Study on HuaQian BaoGan Prescription in the Treatment for Hepatic Fibrosis of Qi Staganation and Blood Stasis Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(08):84.
[2]王长菊,付正英△.乳痛宁巴布剂的制备及体外透皮释放研究[J].西部中医药,2015,28(03):40.
[3]刘成,杨宗国,陆云飞,等.消黄方对大鼠胆汁淤积性肝纤维化的干预作用*[J].西部中医药,2012,25(11):14.
 LIU Cheng,YANG Zong-guo,LU Yun-fei,et al.Therapeutic Effects of XiaoHuangFang on Cholestatic Liver Fibrosis in Rats[J].Western Journal of Traditional Chinese Medicine,2012,25(08):14.
[4]郭守强.苦参碱对肝纤维化大鼠转化生长因子β1表达的影响[J].西部中医药,2014,27(06):13.
 GUO Shouqiang.The Effects of Matrine on the Expressions of TGF-β1 of the Rats with Liver Fibrosis[J].Western Journal of Traditional Chinese Medicine,2014,27(08):13.
[5]闫雪华.恩替卡韦联合复方鳖甲软肝片治疗代偿期乙肝肝硬化疗效观察[J].西部中医药,2014,27(07):84.
 YAN Xuehua.Clinical Observation on Entecavir Combined with Compound BieJia RuanGan Tablets in Treating Decompensated Liver Cirrhosis of Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2014,27(08):84.
[6]陈耀章,李根旺.冬虫夏草对心肝肾的保护作用研究[J].西部中医药,2016,29(04):127.
 CHEN Yaozhang,LI Genwang.Study on the Protective Effects of DongChong XiaCao to Heart, Liver and Kidney[J].Western Journal of Traditional Chinese Medicine,2016,29(08):127.
[7]张玉玲,闫雪华△,谢青.中药联合抗病毒药物治疗HBV所致肝纤维化的研究进展[J].西部中医药,2019,32(06):149.
 ZHANG Yuling,YAN Xuehua,XIE Qing.The Progress of Herbs Joined with Antiviral Drugs in the Treatment for HBV - induced Hepatic Fibrosis[J].Western Journal of Traditional Chinese Medicine,2019,32(08):149.
[8]罗林,徐婷婷,陈卫,等.柴胡皂苷d对蟾蜍离体坐骨神经干电生理特性的影响[J].西部中医药,2022,35(02):16.[doi:10.12174/j.issn.2096-9600.2022.02.04]
 LUO Lin,XU Tingting,CHEN Wei,et al.Effects of Saikosaponin d on Electrophysiological Properties of Isolated Sciatic Nerve Stem of Toads[J].Western Journal of Traditional Chinese Medicine,2022,35(08):16.[doi:10.12174/j.issn.2096-9600.2022.02.04]
[9]段桂姣,王振常,吴珊珊.柔肝化纤颗粒对肝纤维化模型大鼠肝组织超氧化物歧化酶和丙二醛的影响[J].西部中医药,2022,35(04):30.[doi:10.12174/j.issn.2096-9600.2022.04.08]
 DUAN Guijiao,WANG Zhenchang,Wu Shanshan.Effects of Rougan Huaxian Granules on SOD and MDA in Liver Tissue of Rats with Hepatic Fibrosis[J].Western Journal of Traditional Chinese Medicine,2022,35(08):30.[doi:10.12174/j.issn.2096-9600.2022.04.08]
[10]徐俊,戚璐,许杰,等.抗纤软肝颗粒对肝纤维化小鼠肠道黏膜通透性的影响[J].西部中医药,2022,35(07):27.[doi:10.12174/j.issn.2096-9600.2022.07.07]
 XU Jun,QI Lu,XU Jie,et al.Influence of Anti-fibrosis Liver-softening Granules on Intestinal Mucosal Permeability in Hepatic Fibrosis Mice[J].Western Journal of Traditional Chinese Medicine,2022,35(08):27.[doi:10.12174/j.issn.2096-9600.2022.07.07]

备注/Memo

备注/Memo:
陈懿榕(1992—),女,硕士学位。研究方向:血液病的临床与基础研究。国家自然科学基金面上项目(81573775,81873157);上海市科委引导类项目(18401904000);上海市青年科技英才扬帆计划(19YF1445200);上海市卫健委中发办青年基金(2018LQ016);上海中医药大学预算内项目(2021LK067)。
更新日期/Last Update: 2022-08-15